OpenLegislation

Regulation 1 Citation, commencement, and interpretationI1

United Kingdom

(1)

These Regulations may be cited as the Controlled Drugs (Drug Precursors) (Intra-Community Trade and Community External Trade) Regulations 2010 and shall come into force on 15th November 2010.

(2)

In these Regulations—

(a)

the “Intra-Community Trade Regulations” means the Controlled Drugs (Drug Precursors) (Intra-Community Trade) Regulations 2008f1;

(b)

the “Community External Trade Regulations” means the Controlled Drugs (Drug Precursors) (Community External Trade) Regulations 2008f2;

F1(c)

the “2004 Community Regulation” means—

(i)

in respect of Northern Ireland, Regulation (EC) No. 273/2004 of the European Parliament and of the Council dated 11th February 2004 as it has effect in EU law, or;

(ii)

in respect of Great Britain, Regulation (EC) No. 273/2004 of the European Parliament and of the Council dated 11th February 2004;

F2(d)

the “2005 Community Regulation” means—

(i)

in respect of Northern Ireland, Council Regulation (EC) No. 111/2005 dated 22nd December 2004 as it has effect in EU law, or;

(ii)

in respect of Great Britain, Council Regulation (EC) No. 111/2005 dated 22nd December 2004; and

(e)

“scheduled substance” and “operator” have the same meaning as in the 2004 Community Regulation or the 2005 Community Regulation, as the case may be.

Annotations

Textual amendments

F1

Reg. 1(2)(c) substituted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 4(2)(a)

F2

Reg. 1(2)(d) substituted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 4(2)(b)

Commencement

I1

Reg. 1 in force at 15.11.2010, see reg. 1(1)

Footnotes

f1

S.I. 2008/295.

f2

S.I. 2008/296.